Literature DB >> 30474709

Effect of High Glucose on Human Alveolar Macrophage Phenotype and Phagocytosis of Mycobacteria.

Jesse Vance1, Andres Santos1, Laura Sadofsky2, Alyn Morice2, Jorge Cervantes3.   

Abstract

PURPOSE: Diabetes mellitus (DBM) reduces immunological activity and increases susceptibility to various infections, including tuberculosis (TB). Human alveolar macrophage (hAM) functions are altered in DBM.
METHODS: To mimic hyperglycemic conditions in the lung alveolus, we co-cultured a hAM cell line (Daisy cell line) with human umbilical vein endothelial cells for 48 h in the presence of culture media alone, normal glucose (5 mM), and high glucose (22 mM). Using flow cytometry, immunophenotype characterization included cell surface markers CD 11c, CD14, CD16, CD86, CD163, CD169, CD206, CX3CR-1, CSF-1R, and matrix metalloproteinase-9 (MMP9). Phagocytic function was measured by immunofluorescence microscopy at 24 h after inoculation of cells with GFP-expressing Mycobacterium smegmatis.
RESULTS: Direct exposure of AMs to high glucose and exposure in the co-culture system yield different results for the same phenotypic markers. MMP9 expression was increased under both conditions. CD169 and CX3CR1 expressions were decreased when AMs were exposed directly to high glucose but increased under co-culture. Immunofluorescence assay revealed that phagocytosis decreased in AMs when directly exposed to increased glucose levels from 2.5 mM to normal glucose (5 mM), yet AMs under co-culture did not show decreased phagocytosis until concentrations were raised to 25 mM.
CONCLUSION: Alteration in the expression of certain receptors may contribute to defective sentinel function of AMs, promoting susceptibility to TB in a diabetic host. Variability in cell surface marker expression under direct glucose exposure compared to exposure via co-culture reveals that cell signaling between endothelial cells and AMs may play a crucial role in the phenotypic expression of AMs.

Entities:  

Keywords:  Alveolar macrophages; Diabetes; Mycobacteria; Tuberculosis

Mesh:

Substances:

Year:  2018        PMID: 30474709     DOI: 10.1007/s00408-018-0181-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  19 in total

1.  Tuberculosis: from prehistory to Robert Koch, as revealed by ancient DNA.

Authors:  Helen D Donoghue; Mark Spigelman; Charles L Greenblatt; Galit Lev-Maor; Gila Kahila Bar-Gal; Carney Matheson; Kim Vernon; Andreas G Nerlich; Albert R Zink
Journal:  Lancet Infect Dis       Date:  2004-09       Impact factor: 25.071

2.  The in vitro and in vivo effects of microRNA-133a on intervertebral disc destruction by targeting MMP9 in spinal tuberculosis.

Authors:  Xin-Wen Wang; Ji-Jun Liu; Qi-Ning Wu; Shu-Fang Wu; Ding-Jun Hao
Journal:  Life Sci       Date:  2017-07-21       Impact factor: 5.037

3.  Nearly one in 10 US residents has diabetes, CDC reports.

Authors:  Michael McCarthy
Journal:  BMJ       Date:  2014-06-12

Review 4.  Implications of the global increase of diabetes for tuberculosis control and patient care.

Authors:  Rovina Ruslami; Rob E Aarnoutse; Bachti Alisjahbana; Andre J A M van der Ven; Reinout van Crevel
Journal:  Trop Med Int Health       Date:  2010-11       Impact factor: 2.622

5.  Glucose levels affect LL-37 expression in monocyte-derived macrophages altering the Mycobacterium tuberculosis intracellular growth control.

Authors:  Alejandra Montoya-Rosales; Pamela Castro-Garcia; Flor Torres-Juarez; Jose Antonio Enciso-Moreno; Bruno Rivas-Santiago
Journal:  Microb Pathog       Date:  2016-06-02       Impact factor: 3.738

Review 6.  Glucose transport in the lung and its role in liquid movement.

Authors:  Nicolas de Prost; Georges Saumon
Journal:  Respir Physiol Neurobiol       Date:  2007-02-23       Impact factor: 1.931

7.  The impact of chemokine receptor CX3CR1 deficiency during respiratory infections with Mycobacterium tuberculosis or Francisella tularensis.

Authors:  J D Hall; S L Kurtz; N W Rigel; B M Gunn; S Taft-Benz; J P Morrison; A M Fong; D D Patel; M Braunstein; T H Kawula
Journal:  Clin Exp Immunol       Date:  2009-02-10       Impact factor: 4.330

Review 8.  Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.

Authors:  Tamás Rőszer
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

Review 9.  Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages.

Authors:  Leslie Chávez-Galán; Maria L Olleros; Dominique Vesin; Irene Garcia
Journal:  Front Immunol       Date:  2015-05-26       Impact factor: 7.561

10.  Distribution of Matrix Metalloproteinases in Human Atherosclerotic Carotid Plaques and Their Production by Smooth Muscle Cells and Macrophage Subsets.

Authors:  Nynke A Jager; Bastiaan M Wallis de Vries; Jan-Luuk Hillebrands; Niels J Harlaar; René A Tio; Riemer H J A Slart; Gooitzen M van Dam; Hendrikus H Boersma; Clark J Zeebregts; Johanna Westra
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488

View more
  7 in total

Review 1.  Cellular Immunity of Patients with Tuberculosis Combined with Diabetes.

Authors:  Peng Cheng; Liang Wang; Wenping Gong
Journal:  J Immunol Res       Date:  2022-06-01       Impact factor: 4.493

2.  Comparative immunopathogenesis in a murine model of inhalative infection with the mucormycetes Lichtheimia corymbifera and Rhizopus arrhizus.

Authors:  Günter Rambach; Verena Fleischer; Verena Harpf; Michaela Lackner; Andreas Meinitzer; Hans Maier; Johannes Engesser; Cornelia Lass-Flörl; Cornelia Speth
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

3.  The Lung Macrophage in SARS-CoV-2 Infection: A Friend or a Foe?

Authors:  Zaid Abassi; Yara Knaney; Tony Karram; Samuel N Heyman
Journal:  Front Immunol       Date:  2020-06-05       Impact factor: 7.561

4.  Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19.

Authors:  Abu Saleh Md Moin; Thozhukat Sathyapalan; Ilhame Diboun; Stephen L Atkin; Alexandra E Butler
Journal:  Sci Rep       Date:  2021-03-19       Impact factor: 4.379

5.  Impact of Diabetes Mellitus on the Immunity of Tuberculosis Patients: A Retrospective, Cross-Sectional Study.

Authors:  Ruda Wei; Pengchuan Li; Yong Xue; Yinping Liu; Wenping Gong; Weiguo Zhao
Journal:  Risk Manag Healthc Policy       Date:  2022-04-08

6.  Molecular characterization of pre-extensive drug resistant Mycobacterium tuberculosis in Northeast Brazil.

Authors:  Thales Alves Campelo; Luana Nepomuceno Costa Lima; Karla Valéria Batista Lima; Caroliny Soares Silva; Marília Lima da Conceição; José Antonio Pereira Barreto; Aquiles Paulino Peres Mota; Soraya de Oliveira Sancho; Cristiane Cunha Frota
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-02-07       Impact factor: 1.846

Review 7.  The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.

Authors:  Anna Kosyreva; Dzhuliia Dzhalilova; Anastasia Lokhonina; Polina Vishnyakova; Timur Fatkhudinov
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.